Nonlinear dynamics of CAR-T cell therapy

Artur Cesar Fassoni,Denis Carvalho Braga

2024-10-10

Abstract:Chimeric antigen receptor T-cell (CAR-T) therapy is considered a promising cancer treatment. The dynamic response to this therapy can be broadly divided into a short-term phase, ranging from weeks to months, and a long-term phase, ranging from months to years. While the short-term response, encompassing the multiphasic kinetics of CAR-T cells, is better understood, the mechanisms underlying the outcomes of the long-term response, characterized by sustained remission, relapse, or disease progression, remain less understood due to limited clinical data. Here, we analyze the long-term dynamics of a previously validated mathematical model of CAR-T cell therapy. We perform a comprehensive stability and bifurcation analysis, examining model equilibria and their dynamics over the entire parameter space. Our results show that therapy failure results from a combination of insufficient CAR-T cell proliferation and increased tumor immunosuppression. By combining different techniques of nonlinear dynamics, we identify Hopf and Bogdanov-Takens bifurcations, which allow to elucidate the mechanisms behind oscillatory remissions and transitions to tumor escape. In particular, rapid expansion of CAR-T cells leads to oscillatory tumor control, while increased tumor immunosuppression destabilizes these oscillations, resulting in transient remissions followed by relapse. Our study highlights different mathematical tools to study nonlinear models and provides critical insights into the nonlinear dynamics of CAR-T therapy arising from the complex interplay between CAR-T cells and tumor cells.

Populations and Evolution

What problem does this paper attempt to address?

This paper attempts to address the mechanism issues of CAR-T cell therapy in long-term treatment effects. Specifically, the paper focuses on the following aspects:

1. **Long-term dynamic response**: The short-term response (weeks to months) of CAR-T cell therapy has been well understood, but the mechanism of long-term response (months to years) remains unclear. The paper explores the dynamic characteristics of long-term response by analyzing a validated mathematical model.

2. **Causes of treatment failure**: The paper investigates the factors leading to treatment failure, particularly the interaction between insufficient CAR-T cell proliferation and increased tumor immune suppression.

3. **Nonlinear dynamic mechanisms**: By combining different nonlinear dynamic techniques, the paper identifies Hopf and Bogdanov-Takens bifurcations, which help explain the oscillation phenomena in tumor control and the mechanisms of tumor escape.

4. **Impact of model parameters**: The paper provides a detailed analysis of how model parameters affect long-term treatment response, especially how the proliferation rate of CAR-T cells and the immune suppression effect of the tumor determine the treatment outcome.

### Main Findings

- **Causes of treatment failure**: Treatment failure is usually the result of the combined effect of insufficient CAR-T cell proliferation and increased tumor immune suppression.
- **Oscillation phenomena**: Rapidly expanding CAR-T cells can lead to oscillation phenomena in tumor control, while increased tumor immune suppression can disrupt these oscillations, leading to tumor recurrence after a brief remission.
- **Bifurcation phenomena**: Through mathematical analysis, the paper discovers Hopf and Bogdanov-Takens bifurcations, which reveal the complex dynamic relationship between tumor control and escape.

### Therapeutic Implications

- **Proliferation rate of CAR-T cells**: A moderate proliferation rate of CAR-T cells helps achieve stable tumor control, while an excessively high proliferation rate may lead to persistent oscillations, eventually resulting in tumor escape.
- **Immune suppression effect**: The stronger the immune suppression effect of the tumor, the poorer the therapeutic effect of CAR-T cells, potentially leading to rapid tumor recurrence after a brief remission.
- **Importance of initial conditions**: The size of the initial tumor burden has a significant impact on the treatment outcome, with a higher tumor burden potentially helping to activate CAR-T cells, thereby achieving effective tumor control.

Through these analyses, the paper provides important mathematical tools and biological insights for understanding the long-term dynamics of CAR-T cell therapy, which can help optimize treatment strategies and improve therapeutic outcomes.